Pedro Henrique Dias Moura Prazeres

10PUBLICATIONS
43CO-AUTHORS
ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical energy generation (incl. renewables, excl. photovoltaics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 09, 2026
Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness.

Thaís S Ribeiro, Felipe H S Silva, Ana Paula G S Miranda

|Oct 14, 2025
Advancing Cancer Immunotherapy Using Lipid Nanoparticle-Based Approaches.

Pedro Henrique Dias Moura Prazeres, Gabriel Henrique Costa da Silva, Gabriel Vieira Azevedo

|Feb 10, 2025
Antiviral Activity of Electrospun Polyamide Ultrathin Fibers Against SARS-CoV-2 Variant.

Moisés V Santana, Gustavo F Sousa, Millena C S Silva

|Mar 19, 2024
Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression.

Walison Nunes da Silva, Pedro Augusto Carvalho Costa, Sérgio Ricardo Aluotto Scalzo Júnior

|Oct 24, 2023
Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells.

Pedro Henrique Dias Moura Prazeres, Heloísa Ferreira, Pedro Augusto Carvalho Costa

|Oct 10, 2023
Targeting phosphatidylinositol-3-kinase for inhibiting maxillary bone resorption.

Mariana de S Santos, Virgínia T M Lima, Breno R Barrioni

Pageof 2

Frequent Collaborators

5 joint publications

Anderson Oliveira Lobo

3 joint publications

Heloísa Ferreira

3 joint publications

Natália Jordana Alves da Silva

3 joint publications

Alexander Birbrair